View Post

Sudan Ebolavirus Outbreak Expands in Uganda

In Travel Vaccine News by Travel Vaccine

In an accelerated effort to scale up the response to the Sudan Ebolavirus outbreak in Uganda, the World Health Organization (WHO) announced today it is delivering medical supplies, providing logistics, and deploying staff to support the national authorities in halting the spread of the deadly virus.
As of September 22, 2022, seven cases, including one death, have been confirmed to have contracted Sudan Ebolavirus. 
And forty-three contacts have been identified, with ten people receiving treatment at the regional referral hospital in Mubende, Uganda.

View Post

Africa Acts to Stop Meningitis Outbreaks

In Travel Vaccine News by Travel Vaccine

With the COVID-19 pandemic delaying meningitis vaccination campaigns for more than 50 million children in Africa, the World Health Organization (WHO) region is at a heightened risk of outbreaks of meningitis type A, which has nearly been eliminated on the continent.
In a race against time, the WHO and partners recently launched a roadmap to stop bacterial meningitis outbreaks by 2030.
Based on reports from countries, the WHO found that meningitis control activities were reduced by 50% in 2020 compared with 2019, with a slight improvement in 2021.

View Post

Sudan Ebola Outbreak Declared in Africa

In Travel Vaccine News by Travel Vaccine

The World Health Organization (WHO) announced today the Uganda Virus Research Institute confirmed a Sudan ebolavirus case after testing a sample taken from a 24-year-old male in Mubende district in the central part of the country.
The confirmation on September 20, 2022, follows an investigation by the National Rapid Response team of six suspicious deaths in the district in September 2022.
Furthermore, the WHO stated eight suspected cases are receiving care in a health facility.
Uganda last reported a Sudan ebolavirus outbreak in 2012.

View Post

Long-Ebola Needs Extensive Research

In Travel Vaccine News by Travel Vaccine

Lingering symptoms have been reported by Ebola virus disease (EVD) survivors in Africa over the past few years. 
For example, the Liberian Ebola Survivors Cohort study published on September 6, 2022, found headache, fatigue, joint pain, muscle pain, hearing loss, visual loss, and numbness of hands or feet were longitudinally assessed among EVD participants.
At baseline, about 75% reported at least one symptom, and 85% significantly interfered with life.

View Post

Measles Returns to Australia in 2022

In Travel Vaccine News by Travel Vaccine

Australia's NSW Health recently confirmed the first local case of measles since February 2020. This person developed symptoms after returning to Sydney and is now isolated in a hospital.
This adult acquired the infection while traveling in Asia in August 2022.
As of September 13, 2022, NSW Health says the person spent time in the following Sydney locations while infectious with the measles virus:

View Post

$18 Billion Needed to Defeat HIV, Malaria, and Tuberculosis

In Travel Vaccine News by Travel Vaccine

The Global Fund’s 2022 Results Report released today indicates a significant rebound for programs working to defeat HIV, tuberculosis (TB), and malaria.
In 2020, the COVID-19 pandemic had a devastating impact on the fight against these three diseases.
When the pandemic hit countries where the Global Fund works, the partnership rapidly mounted a response to deliver additional resources. 
Since March 2020, the Global Fund has invested more than US $4.4 billion to fight the pandemic and mitigate its impact on HIV, TB, and malaria.

View Post

New York's Poliovirus Disaster Emergency Could Disrupt Travel

In Travel Vaccine News by Travel Vaccine

Investigations into wastewater samples continue to reveal poliovirus in unexpected locations worldwide, including another New York county and again in London, England.
As of September 11, 2022, the World Health Organization (WHO) continues to affirm 'that the risk of international spread of poliovirus remains a Public Health Emergency of International Concern.'

View Post

Africa's Yellow Fever Outbreaks Intensified in 2022

In Travel Vaccine News by Travel Vaccine

The WHO African Region recently confirmed that the threat of yellow fever outbreaks continues to affect African countries, with twenty-seven countries now classified as high-risk by the Eliminate Yellow fever Epidemics (EYE) global strategy.
The WHO's EYE strategy aims to enable every person in yellow fever at-risk countries to be protected against the disease.
Currently, the WHO assesses the risk of an outbreak at the regional level to be high. 

View Post

USA Returns to Pre-Pandemic Airport Activity

In Travel Vaccine News by Travel Vaccine

During the Labor Day 2022 holiday weekend, the U.S. Transportation Security Administration (TSA) screened 8.76 million travelers between Friday and Monday. This airport activity represents 102% of the volume for the same pre-pandemic holiday weekend in 2019.
Friday marked the heaviest travel day when TSA Security Officers screened 2.48 million passengers.
And it is the first time that a holiday weekend TSA passenger screening volume exceeds that of 2019.

View Post

Argentina's Pneumonia Outbreak De-Mystified

In Travel Vaccine News by Travel Vaccine

The Regional Office for the Americas of the World Health Organization (WHO) recently reported a total of eleven cases of pneumonia, including four deaths, with the onset of symptoms between August 18 and 25, 2022.
No secondary cases have been identified of these pneumonia cases linked to the same clinic in San Miguel de Tucumán.
The cluster is limited to eight (8) health care workers and three patients from the private clinic.